AIDS Treatment News logo      

July 1, 2009

HIV and ARV Therapy Accelerate Bone Loss

"Bone loss is common among people living with HIV before they begin antiretroviral (ARV) therapy, and it worsens upon starting treatment, especially if the regimen contains Combivir (zidovudine plus lamivudine), according to a new report published in the July 17 issue of AIDS. Though severe bone loss is associated with an increased risk of serious bone fractures, the Dutch study authors remind readers that this might be less of a concern among young people living with HIV. "

Read more in POZ, June 30, 2009.